Ligand-dependent and-independent regulation of PPARγ and orphan nuclear receptors

Science Signaling

Volumn 1, Issue 48, 2008, Pages

  Xu, H Eric ^a   Li, Yong ^b  

^a VAN ANDEL RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL RECEPTOR; LIGAND; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; GENETICS; METABOLISM; PROTEIN BINDING; PROTEIN TERTIARY STRUCTURE;

LIGANDS; MODELS, MOLECULAR; PPAR GAMMA; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, CYTOPLASMIC AND NUCLEAR;

EID: 60849087703     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.148pe52c     Document Type: Review

References (35)

1. D. J. Mangelsdorf, C. Thummel, M. Beato, P. Herrlich, G. Schutz, K. Umesono, B. Blumberg, P. Kastner, M. Mark, P. Chambon, R. M. Evans, The nuclear receptor superfamily: The second decade. Cell 83, 835-839 (1995).
2. Y. Li, M. H. Lambert, H. E. Xu, Activation of nuclear receptors: A perspective from structural genomics. Structure 11, 741-746 (2003).
3. S. A. Kliewer, J. M. Lehmann, T. M. Willson, Orphan nuclear receptors: Shifting endocrinology into reverse. Science 284, 757-760 (1999).
4. J. M. Lehmann, L. B. Moore, T. A. Smith-Oliver, W. O. Wilkison, T. M. Willson, S. A. Kliewer, An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPAR γ). J. Biol. Chem. 270, 30221-30229 (1995).
5. R. M. Evans, G. D. Barish, Y. X. Wang, PPARs and the complex journey to obesity. Nat. Med. 10, 355-361 (2004).
6. M. Lehrke, M. A. Lazar, The many faces of PPARγ. Cell 123, 993-999 (2005).
7. J. N. Feige, L. Gelman, L. Michalik, B. Desvergne, W. Wahli, From molecular action to physiological outputs: Peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions. Prog. Lipid Res. 45, 120-159 (2006).
8. P. Tontonoz, E. Hu, B. M. Spiegelman, Stimulation of adipogenesis in fibroblasts by PPAR γ 2, a lipid-activated transcription factor. Cell 79, 1147-1156 (1994).
9. P. Tontonoz, E. Hu, R. A. Graves, A. I. Budavari, B. M. Spiegelman, mPPAR γ 2: Tissue-specific regulator of an adipocyte enhancer. Genes Dev. 8, 1224-1234 (1994).
10. Y. Barak, M. C. Nelson, E. S. Ong, Y. Z. Jones, P. Ruiz-Lozano, K. R. Chien, A. Koder, R. M. Evans, PPAR γ is required for placental, cardiac, and adipose tissue development. Mol. Cell 4, 585-595 (1999).
11. E. D. Rosen, P. Sarraf, A. E. Troy, G. Bradwin, K. Moore, D. S. Milstone, B. M. Spiegelman, R. M. Mortensen, PPAR γ is required for the differentiation of adipose tissue in vivo and in vitro. Mol. Cell 4, 611-617 (1999).
12. R. T. Gampe Jr., V. G. Montana, M. H. Lambert, A. B. Miller, R. K. Bledsoe, M. V. Milburn, S. A. Kliewer, T. M. Willson, H. E. Xu, Asymmetry in the PPARγ/RXRα crystal structure reveals the molecular basis of heterodimerization among nuclear receptors. Mol. Cell 5, 545-555 (2000).
13. R. T. Nolte, G. B. Wisely, S. Westin, J. E. Cobb, M. H. Lambert, R. Kurokawa, M. G. Rosenfeld, T. M. Willson, C. K. Glass, M. V. Milburn, Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ. Nature 395, 137-143 (1998).
14. Single-letter abbreviations for the amino acid residues are as follows: E, Glu; H, His; L, Leu; P, Pro; Q, Gln; and Y, Tyr.
15. H. E. Xu, M. H. Lambert, V. G. Montana, K. D. Plunket, L. B. Moore, J. L. Collins, J. A. Oplinger, S. A. Kliewer, R. T. Gampe Jr., D. D. McKee, J. T. Moore, T. M. Willson, Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptors. Proc. Natl. Acad. Sci. U.S.A. 98, 13919-13924 (2001).
16. S. A. Kliewer, S. S. Sundseth, S. A. Jones, P. J. Brown, G. B. Wisely, C. S. Koble, P. Devchand, W. Wahli, T. M. Willson, J. M. Lenhard, J. M. Lehmann, Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ. Proc. Natl. Acad. Sci. U.S.A. 94, 4318-4323 (1997).
17. B. M. Forman, J. Chen, R. M. Evans, Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator- activated receptors α and δ. Proc. Natl. Acad. Sci. U.S.A. 94, 4312-4317 (1997).
18. P. Sarraf, E. Mueller, W. M. Smith, H. M. Wright, J. B. Kum, L. A. Aaltonen, A. de la Chapelle, B. M. Spiegelman, C. Eng, Loss-of-function mutations in PPAR γ associated with human colon cancer. Mol. Cell 3, 799-804 (1999).
19. C. J. Walkey, B. M. Spiegelman, A functional peroxisome proliferator-activated receptor-γ ligandbinding domain is not required for adipogenesis. J. Biol. Chem. 283, 24290-24294 (2008).
20. Y. Li, J. Zhang, F. J. Schopfer, D. Martynowski, M. T. Garcia-Barrio, A. Kovach, K. Suino-Powell, P. R. Baker, B. A. Freeman, Y. E. Chen, H. E. Xu, Molecular recognition of nitrated fatty acids by PPAR γ. Nat. Struct. Mol. Biol. 15, 865-867 (2008).
21. T. Itoh, L. Fairall, K. Amin, Y. Inaba, A. Szanto, B. L. Balint, L. Nagy, K. Yamamoto, J. W. Schwabe, Structural basis for the activation of PPARγ by oxidized fatty acids. Nat. Struct. Mol. Biol. 15, 924-931 (2008).
22. Y. Li, A. Kovach, K. Suino-Powell, D. Martynowski, H. E. Xu, Structural and biochemical basis for the binding selectivity of peroxisome proliferatoractivated receptor γ to PGC-1α. J. Biol. Chem. 283, 19132-19139 (2008).
23. I. Tzameli, H. Fang, M. Ollero, H. Shi, J. K. Hamm, P. Kievit, A. N. Hollenberg, J. S. Flier, Regulated production of a peroxisome proliferator-activated receptor-γ ligand during an early phase of adipocyte differentiation in 3T3-L1 adipocytes. J. Biol. Chem. 279, 36093-36102 (2004).
24. D. S. Straus, C. K. Glass, Anti-inflammatory actions of PPAR ligands: New insights on cellular and molecular mechanisms. Trends Immunol. 28, 551-558 (2007).
25. P. Tontonoz, B. M. Spiegelman, Fat and beyond: The diverse biology of PPARγ. Annu. Rev. Biochem. 77, 289-312 (2008).
26. S. Rocchi, F. Picard, J. Vamecq, L. Gelman, N. Potier, D. Zeyer, L. Dubuquoy, P. Bac, M. F. Champy, K. D. Plunket, L. M. Leesnitzer, S. G. Blanchard, P. Desreumaux, D. Moras, J. P. Renaud, J. Auwerx, A unique PPARγ ligand with potent insulin-sensitizing yet weak adipogenic activity. Mol. Cell 8, 737-747 (2001).
27. Y. Li, M. A. Lazar, Differential gene regulation by PPARγ agonist and constitutively active PPARγ2. Mol. Endocrinol. 16, 1040-1048 (2002).
28. Z. Wang, G. Benoit, J. Liu, S. Prasad, P. Aarnisalo, X. Liu, H. Xu, N. P. Walker, T. Perlmann, Structure and function of Nurr1 identifies a class of ligand-independent nuclear receptors. Nature 423, 555-560 (2003).
29. Y. Li, M. Choi, G. Cavey, J. Daugherty, K. Suino, A. Kovach, N. C. Bingham, S. A. Kliewer, H. E. Xu, Crystallographic identification and functional characterization of phospholipids as ligands for the orphan nuclear receptor steroidogenic factor- Mol. Cell 17, 491-502 (2005).
30. I. N. Krylova, E. P. Sablin, J. Moore, R. X. Xu, G. M. Waitt, J. A. MacKay, D. Juzumiene, J. M. Bynum, K. Madauss, V. Montana, L. Lebedeva, M. Suzawa, J. D. Williams, S. P. Williams, R. K. Guy, J. W. Thornton, R. J. Fletterick, T. M. Willson, H. A. Ingraham, Structural analyses reveal phosphatidyl inositols as ligands for the NR5 orphan receptors SF-1 and LRH-1. Cell 120, 343-355 (2005).
31. Y. Zhan, X. Du, H. Chen, J. Liu, B. Zhao, D. Huang, G. Li, Q. Xu, M. Zhang, B. C. Weimer, D. Chen, Z. Cheng, L. Zhang, Q. Li, S. Li, Z. Zheng, S. Song, Y. Huang, Z. Ye, W. Su, S. C. Lin, Y. Shen, Q. Wu, Cytosporone B is an agonist for nuclear orphan receptor Nur77. Nat. Chem. Biol. 4, 548-556 (2008).
32. S. Chintharlapalli, R. Burghardt, S. Papineni, S. Ramaiah, K. Yoon, S. Safe, Activation of Nur77 by selected 1, 1-Bis(3′-indolyl)-1-(p- substituted phenyl)methanes induces apoptosis through nuclear pathways. J. Biol. Chem. 280, 24903-24914 (2005).
33. K. Suino-Powell, Y. Xu, C. Zhang, Y. G. Tao, W. D. Tolbert, S. S. Simons Jr., H. E. Xu, Doubling the size of the glucocorticoid receptor ligand binding pocket by deacylcortivazol. Mol. Cell. Biol. 28, 1915-1923 (2008).
34. S. W. Kruse, K. Suino-Powell, X. E. Zhou, J. E. Kretschman, R. Reynolds, C. Vonrhein, Y. Xu, L. Wang, S. Y. Tsai, M. J. Tsai, H. E. Xu, Identification of COUP-TFII orphan nuclear receptor as a retinoic acid-activated receptor. PLoS Biol. 6, e227 (2008).
35. We thank D. Nadziejka for editing the manuscript. This work was supported in part by the Jay and Betty Van Andel Foundation (H.E.X.), U.S. National Institutes of Health grants DK071662 and DK066202 (H.E.X.) and HL089301 (H.E.X. and Y.L.).